Simplify增强型收益主动型ETF HIGH 深 沪
等待开盘 03-26 09:30:00 美东时间
21.44
0.000
0.00%
华盛通- 最 高21.5058
- 今 开21.44
- 成交量 8549股
- 最 低 21.4201
- 昨 收 21.44
- 总市值 9112.00万
- 52周最高 23.8441
- 市盈率 静 --
- 换手率 0.20%
- 52周最低 19.41
- 委 比 85.71%
- 总股本 425.00万
- 历史最高 23.66
- 量 比 0.30
- 振 幅 0.40%
- 历史最低 18.1672
- 每 手 1
- 风险率 0.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Riverview Bancorp Inc - Reclassifies Entire Htm Securities To Afs Securities
BRIEF-Riverview Bancorp Inc - Reclassifies Entire Htm Securities To Afs Securities Riverview Bancorp Inc RVSB.O : RIVERVIEW BANCORP INC - RECLASSIFIES ENTIRE HTM SECURITIES TO AFS SECURITIES RIVERVIEW BANCORP INC - SELLS $149.3 MILLION IN SECURITIES FOR ESTIMATED PRE-TAX LOSS OF $11.4 MILLION RIVERV
03-25 21:02
Paychex Q3 revenue beats expectations on Paycor acquisition
Paychex Q3 revenue beats expectations on Paycor acquisition Overview US human capital management firm's fiscal Q3 revenue grew 20%, beating analyst expectations Adjusted EPS for fiscal Q3 rose 15%, beating analyst expectations Quarterly growth driven by Paycor acquisition and higher revenue per clie
03-25 20:41
BRIEF-Sarepta Announces First Clinical Data From Sirna Pipeline Targeting Fshd1 And Dm1
BRIEF-Sarepta Announces First Clinical Data From Sirna Pipeline Targeting Fshd1 And Dm1 Sarepta Therapeutics Inc SRPT.O : SAREPTA ANNOUNCES FIRST CLINICAL DATA FROM SIRNA PIPELINE TARGETING FSHD1 AND DM1 SAREPTA THERAPEUTICS INC - SIRNA ACHIEVES HIGH MUSCLE CONCENTRATIONS WITHOUT DOSE LIMITING TOXIC
03-25 20:29
Maze Therapeutics reports bigger-than-expected Q4 loss on higher R&D costs
Maze Therapeutics reports bigger-than-expected Q4 loss on higher R&D costs Overview US biopharmaceutical firm's Q4 net loss missed analyst expectations, income from operations also missed Pretax profit for Q4 slightly beat analyst estimates Company announced positive Phase 2 HORIZON trial data for M
03-25 19:10
LIVE MARKETS-Oil just right for Fed hawkishness
LIVE MARKETS-Oil just right for Fed hawkishness Adds blog post STOXX up 1.4% Nearly all European stocks sectors in positive territory S&P futures up 0.8% Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research
03-25 18:58
BRIEF-Nov Inc Announces $200 Million Capital Expansion For Offshore And High-Co₂ Solutions
BRIEF-Nov Inc Announces $200 Million Capital Expansion For Offshore And High-Co₂ Solutions March 25 (Reuters) - Nov Inc NOV.N : NOV INC - PLANS TO ROUGHLY DOUBLE CAPACITY OF ITS SUBSEA FLEXIBLE PIPE MANUFACTURING FACILITY IN AÇU, BRAZIL OVER NEXT THREE YEARS (ADDS DROPPED SOURCE) NOV INC - ANNOUNCES
03-25 18:38
U.S. RESEARCH ROUNDUP-Amazon, Diamondback Energy, Matador Resources
U.S. RESEARCH ROUNDUP-Amazon, Diamondback Energy, Matador Resources March 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amazon, Diamondback Energy and Matador Resources on Wednesday. HIGHLIGHTS * Amazon AMZN.O : JP
03-25 16:01
BioAge Labs full-year collaboration revenue beats estimates
BioAge Labs full-year collaboration revenue beats estimates Overview US biopharmaceutical firm posts full-year collaboration revenue, beating analyst expectations Net loss for 2025 widened as R&D and G&A expenses increased Company completed $132.3 mln upsized follow-on public offering to fund operat
03-24 21:09
BRIEF-Rare Element Resources Provides Rare Earth Project Update
BRIEF-Rare Element Resources Provides Rare Earth Project Update Rare Element Resources Ltd REEMF.PK : RARE ELEMENT RESOURCES PROVIDES RARE EARTH PROJECT UPDATE RARE ELEMENT RESOURCES LTD - COMMENCES OPERATIONS AT RARE EARTH DEMONSTRATION PLANT IN WYOMING RARE ELEMENT RESOURCES LTD - PLANT OPERATIONS
03-24 20:38
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, Insmed, Sunoco
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, Insmed, Sunoco March 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apogee Therapeutics, Insmed and Sunoco, on Tuesday. HIGHLIGHTS * Apogee Therapeutics Inc APGE.O : Stephen
03-24 15:39
